Details for Patent: 12,083,227
✉ Email this page to a colleague
Which drugs does patent 12,083,227 protect, and when does it expire?
Patent 12,083,227 protects ORIAHNN (COPACKAGED) and is included in one NDA.
This patent has forty-one patent family members in fourteen countries.
Drugs Protected by US Patent 12,083,227
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Abbvie | ORIAHNN (COPACKAGED) | elagolix sodium,estradiol,norethindrone acetate; elagolix sodium | CAPSULE;ORAL | 213388-001 | May 29, 2020 | RX | Yes | Yes | 12,083,227 | ⤷ Subscribe | Y | MANAGEMENT OF HEAVY MENSTRUAL BLEEDING ASSOCIATED WITH UTERINE LEIOMYOMAS (FIBROIDS) | ⤷ Subscribe | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
International Family Members for US Patent 12,083,227
| Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
|---|---|---|---|---|---|
| Australia | 2018317472 | ⤷ Subscribe | |||
| Australia | 2018317473 | ⤷ Subscribe | |||
| Australia | 2018419533 | ⤷ Subscribe | |||
| Brazil | 112020003380 | ⤷ Subscribe | |||
| Brazil | 112020003388 | ⤷ Subscribe | |||
| >Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |
